Literature DB >> 6861204

Analysis of the hemagglutinin glycoprotein from mutants of vaccinia virus that accumulates on the nuclear envelope.

H Shida, S Matsumoto.   

Abstract

We isolated mutants whose vaccinia hemagglutinin (HA) accumulates on nuclear envelopes and the rough endoplasmic reticulum. Mutant HA must be blocked at a pre-Golgi step because it has high-mannose-type carbohydrates but no fucose. Neither N- nor O-glycosidically linked carbohydrates are involved in the transport defect of the mutant HA, because tunicamycin, an inhibitor of N-type glycosylation, has no effect, and O-type glycosylation takes place in the Golgi organelle. The unglycosylated form of the mutant HA synthesized in the presence of tunicamycin is 3000 daltons larger than the wild type. This higher molecular weight is related to the transport defect. HAs translated in vitro also show this difference, evidence that it reflects mutation in the HA structural gene. Portions of HAs that project into the cytoplasm seem to account for this weight difference. Thus the cytoplasmic tail of glycoprotein has an important function in transport out of the rough endoplasmic reticulum.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6861204     DOI: 10.1016/0092-8674(83)90424-5

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  22 in total

1.  Aptamers recognizing glycosylated hemagglutinin expressed on the surface of vaccinia virus-infected cells.

Authors:  Parag Parekh; Zhiwen Tang; Peter C Turner; Richard W Moyer; Weihong Tan
Journal:  Anal Chem       Date:  2010-10-15       Impact factor: 6.986

Review 2.  The vaccinia virus A56 protein: a multifunctional transmembrane glycoprotein that anchors two secreted viral proteins.

Authors:  Brian C DeHaven; Kushol Gupta; Stuart N Isaacs
Journal:  J Gen Virol       Date:  2011-06-29       Impact factor: 3.891

3.  Expression and nuclear envelope localization of biologically active fusion glycoprotein gB of herpes simplex virus in mammalian cells using cloned DNA.

Authors:  M A Ali; M Butcher; H P Ghosh
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

4.  Hemagglutinin-neuraminidase glycoprotein as a determinant of pathogenicity in mumps virus hamster encephalitis: analysis of mutants selected with monoclonal antibodies.

Authors:  A Löve; R Rydbeck; K Kristensson; C Orvell; E Norrby
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

5.  Variants of vaccinia virus hemagglutinin altered in intracellular transport.

Authors:  H Shida
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

6.  A deletion that includes the segment coding for the signal peptidase cleavage site delays release of Saccharomyces cerevisiae acid phosphatase from the endoplasmic reticulum.

Authors:  R Haguenauer-Tsapis; M Nagy; A Ryter
Journal:  Mol Cell Biol       Date:  1986-02       Impact factor: 4.272

7.  A membrane-associated, carbohydrate-modified form of the v-abl protein that cannot be phosphorylated in vivo or in vitro.

Authors:  S M Watanabe; N E Rosenberg; O N Witte
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

8.  Molecular characterization of the vaccinia virus hemagglutinin gene.

Authors:  C K Brown; P C Turner; R W Moyer
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

9.  Effects and virulences of recombinant vaccinia viruses derived from attenuated strains that express the human T-cell leukemia virus type I envelope gene.

Authors:  H Shida; Y Hinuma; M Hatanaka; M Morita; M Kidokoro; K Suzuki; T Maruyama; F Takahashi-Nishimaki; M Sugimoto; R Kitamura
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

10.  Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network.

Authors:  M Schmelz; B Sodeik; M Ericsson; E J Wolffe; H Shida; G Hiller; G Griffiths
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.